QTORIN 3.9% rapamycin anhydrous gel
PALV-05
Phase 3 small_molecule completed
Quick answer
QTORIN 3.9% rapamycin anhydrous gel for Pachyonychia Congenita is a Phase 3 program (small_molecule) at PALVELLA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PALVELLA THERAPEUTICS, INC.
- Indication
- Pachyonychia Congenita
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed